Literature DB >> 11290818

Effect of mutations of N- and C-terminal charged residues on the activity of LCAT.

F Peelman1, B Vanloo, J L Verschelde, C Labeur, H Caster, J Taveirne, A Verhee, N Duverger, J Vandekerckhove, J Tavernier, M Rosseneu.   

Abstract

On the basis of structural homology calculations, we previously showed that lecithin:cholesterol acyltransferase (LCAT), like lipases, belongs to the alpha/beta hydrolase fold family. As there is higher sequence conservation in the N-terminal region of LCAT, we investigated the contribution of the N- and C-terminal conserved basic residues to the catalytic activity of this enzyme. Most basic, and some acidic residues, conserved among LCAT proteins from different species, were mutated in the N-terminal (residues 1;-210) and C-terminal (residues 211;-416) regions of LCAT. Measurements of LCAT-specific activity on a monomeric substrate, on low density lipoprotein (LDL), and on reconstituted high density lipoprotein (rHDL) showed that mutations of N-terminal conserved basic residues affect LCAT activity more than those in the C-terminal region. This agrees with the highest conservation of the alpha/beta hydrolase fold and structural homology with pancreatic lipase observed for the N-terminal region, and with the location of most of the natural mutants reported for human LCAT. The structural homology between LCAT and pancreatic lipase further suggests that residues R80, R147, and D145 of LCAT might correspond to residues R37, K107, and D105 of pancreatic lipase, which form the salt bridges D105-K107 and D105-R37. Natural and engineered mutations at residues R80, D145, and R147 of LCAT are accompanied by a substantial decrease or loss of activity, suggesting that salt bridges between these residues might contribute to the structural stability of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290818

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices.

Authors:  Mary G Sorci-Thomas; Shaila Bhat; Michael J Thomas
Journal:  Clin Lipidol       Date:  2009-02

2.  Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.

Authors:  Marcelo J A Amar; Robert D Shamburek; Boris Vaisman; Catherine L Knapper; Bernhard Foger; Robert F Hoyt; Silvia Santamarina-Fojo; Hollis B Brewer; Alan T Remaley
Journal:  Metabolism       Date:  2009-04       Impact factor: 8.694

3.  Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays.

Authors:  Cristina Sensi; Sara Simonelli; Ilaria Zanotti; Gabriella Tedeschi; Giulia Lusardi; Guido Franceschini; Laura Calabresi; Ivano Eberini
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

4.  High-Throughput Screening of Acyl-CoA Thioesterase I Mutants Using a Fluid Array Platform.

Authors:  Ji Won Lim; Kwang Soo Shin; Young Shin Ryu; Yongjoo Lee; Sung Kuk Lee; Taesung Kim
Journal:  ACS Omega       Date:  2019-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.